GlobalData on MSN3d
Supernus’s stock sinks after depression drug fails trial
Supernus Pharmaceutical’s stock declined following the release of disappointing Phase IIb trial results for SPN-820, an ...
Medscape5d
The Geriatric Depression Scale (GDS)
the Geriatric Depression Scale (GDS), first created by Yesavage et al., has been tested and used extensively with the older population. It is a brief questionnaire in which participants are asked ...
Knowridge10d
A simple test to check your relationship this Valentine’s Day
Just in time for Valentine’s Day, researchers at Stockholm University have created a new way to measure relationship ...
Medscape4d
Combination of Pharmacotherapy and Psychotherapy in the Treatment of Chronic Depression
The primary efficacy outcome was the response to treatment, which was defined as an at least 50% decrease on a depression scale from baseline to the end of treatment. Secondary efficacy outcomes ...
Supernus Pharmaceuticals Stock Falls On Disappointing Data From Treatment-Resistant Depression Trial
Supernus' SPN-820 Phase 2b study in treatment-resistant depression failed to meet its primary endpoint, prompting further ...
Is Depression Aging You Faster? Scientists Reveal a 30% Increase in Health Risks
Depression isn’t just a mental health challenge — it takes a toll on the entire body. A study tracking over 170,000 adults ...
BioSpace3d
Supernus Falls Back on CNS Portfolio as Depression Drug Fails Mid-Stage Study
After SPN-820's failure, Supernus is relying on its non-stimulant ADHD drug Qelbree and the recently approved Parkinson’s ...